Dose‐dependent association of proton pump inhibitors use with gastric intestinal metaplasia among Helicobacter pylori‐positive patients

BACKGROUND: Gastric intestinal metaplasia is a pre‐cancerous condition associated with multiple factors. OBJECTIVE: We evaluated whether cumulative proton pump inhibitor dose is associated with the diagnosis of gastric intestinal metaplasia while controlling for multiple variables. METHODS: We retro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:United European Gastroenterol J
Egile Nagusiak: Snir, Yifat, Leibovitzh, Haim, Leibovici‐Weissman, Yaara, Vilkin, Alex, Cohen, Arnon D., Shochat, Tzippy, Niv, Yaron, Dotan, Iris, Feldhamer, Ilan, Boltin, Doron, Levi, Zohar
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2021
Gaiak:
Neurogastroenterology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8259238/
https://ncbi.nlm.nih.gov/pubmed/32962566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620951403
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak